157
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Magnetic resonance enterography perfusion parameters reveal complex changes in affected and unaffected segments in Crohn’s disease

, , , &
Pages 1041-1048 | Received 25 May 2020, Accepted 22 Jul 2020, Published online: 06 Aug 2020

References

  • Cellier C, Sahmoud T, Froguel E, et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn’s disease. A prospective multicentre study of 121 cases. The Groupe d’Etudes Therapeutiques des. Affections Inflammatoires Digestives. Gut. 1994;35(2):231–235.
  • Rimola J, Alvarez-Cofiño A, Pérez-Jeldres T, et al. Comparison of three magnetic resonance enterography indices for grading activity in Crohn’s disease. J Gastroenterol. 2017;52(5):585–593.
  • Pariente B, Peyrin-Biroulet L, Cohen L, et al. Gastroenterology review and perspective: the role of cross-sectional imaging in evaluating bowel damage in Crohn disease. AJR Am J Roentgenol. 2011;197(1):42–49.
  • Bouhnik Y, Carbonnel F, Laharie D, et al. Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. Gut. 2018;67(1):53–60.
  • Gribbestad IS, Gjesdal KI, Nilsen G, et al. An introduction to dynamic contrast enhanced MRI in oncology. In: Jackson A, Buckley DL, Parker GJM, editors. Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology. Medical radiology (Diagnostic Imaging). Berlin, Heidelberg: Springer; 2005. DOI:10.1007/3-540-26420-5_1
  • Blasel S, Zagorcic A, Jurcoane A, et al. Perfusion MRI in the evaluation of suspected glioblastoma recurrence. J Neuroimaging. 2016;26(1):116–123.
  • Chang R-F, Chen H-H, Chang Y-C, et al. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI. Magn Reson Imaging. 2016;34(6):809–819.
  • Barrett T, Gill AB, Kataoka MY, et al. DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study. Magn Reson Med. 2012;67(3):778–785.
  • Chen BB, Shih TTF. DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker. World J Gastroenterol. 2014;20(12):3125–3134.
  • Armbruster M, D’Anastasi M, Holzner V, et al. Improved detection of a tumorous involvement of the mesorectal fascia and locoregional lymph nodes in locally advanced rectal cancer using DCE-MRI. Int J Colorectal Dis. 2018;33(7):901–909.
  • Liu J, Pedoia V, Heilmeier U, et al. High-temporospatial-resolution dynamic contrast-enhanced (DCE) wrist MRI with variable-density pseudo-random circular Cartesian undersampling (CIRCUS) acquisition: evaluation of perfusion in rheumatoid arthritis patients. NMR Biomed. 2016;29(1):15–23.
  • Orguc S, Tikiz C, Aslanalp Z, et al. Comparison of OMERACT-RAMRIS scores and computer-aided dynamic magnetic resonance imaging findings of hand and wrist as a measure of activity in rheumatoid arthritis. Rheumatol Int. 2013;33(7):1837–1844.
  • Van Hoof RHM, Vöö SA, Sluimer JC, et al. Vessel wall and adventitial DCE-MRI parameters demonstrate similar correlations with carotid plaque microvasculature on histology. J Magn Reson Imaging. 2017;46(4):1053–1059.
  • Danese S, Sans M, de la Motte C, et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology. 2006;130(7):2060–2073.
  • Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast. Radiology. 2006;238(2):517–530.
  • Del Vescovo R, Sansoni I, Caviglia R, et al. Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn’s disease. Abdom Imaging. 2008;33(4):417–424.
  • Oto A, Kayhan A, Williams JTB, et al. Active Crohn’s disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging. J Magn Reson Imaging. 2011;33(3):615–624.
  • Deban L, Correale C, Vetrano S, et al. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol. 2008;172(6):1457–1466.
  • Sinha R, Verma R, Verma S, et al. MR enterography of Crohn disease: part 2, imaging and pathologic findings. AJR Am J Roentgenol. 2011;197(1):80–85.
  • Horsthuis K, Lavini C, Bipat S, et al. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity. Radiology. 2009;251(2):380–387.
  • Pauls S, Kratzer W, Rieber A, et al. [Quantifying the inflammatory activity in Crohn's disease using CE dynamic MRI]. Rofo. 2003;175(8):1093–1099.
  • Florie J, Wasser MN, Arts-Cieslik K, et al. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn’s disease. AJR Am J Roentgenol. 2006;186(5):1384–1392.
  • Giusti S, Faggioni L, Neri E, et al. Dynamic MRI of the small bowel: usefulness of quantitative contrast-enhancement parameters and time-signal intensity curves for differentiating between active and inactive Crohn’s disease. Abdom Imaging. 2010;35(6):646–653.
  • Ziech ML, Lavini C, Caan MW, et al. Dynamic contrast-enhanced MRI in patients with luminal Crohn’s disease. Eur J Radiol. 2012;81(11):3019–3027.
  • Tielbeek JA, Ziech ML, Li Z, et al. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn’s disease assessment with histopathology of surgical specimens. Eur Radiol. 2014;24(3):619–629.
  • Bhatnagar G, Dikaios N, Prezzi D, et al. Changes in dynamic contrast-enhanced pharmacokinetic and diffusion-weighted imaging parameters reflect response to anti-TNF therapy in Crohn’s disease. Br J Radiol. 2015;88(1055):4–6.
  • Zhu J, Zhang F, Zhou J, at el. Assessment of therapeutic response in Crohn’s disease using quantitative dynamic contrast enhanced MRI (DCE-MRI) parameters: a preliminary study. Medicine. 2017;96(32):e7759.
  • Pupillo VA, Di Cesare E, Frieri G, et al. Assessment of inflammatory activity in Crohn’s disease by means of dynamic contrast-enhanced MRI. Radiol Med. 2007;112(6):798–809.
  • Zhu J, Zhang F, Luan Y, et al. Can dynamic contrast-enhanced MRI (DCE-MRI) and Diffusion-Weighted MRI (DW-MRI) evaluate inflammation disease: a preliminary study of Crohn’s disease. Medicine. 2016;95(14):e3239.
  • Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weightedMRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10(3):223–232.
  • Taylor SA, Punwani S, Rodriguez-Justo M, et al. Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination – pilot study. Radiology. 2009;251(2):369–379.
  • Oto A, Fan X, Mustafi D, et al. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn’s Disease pilot study. Acad Radiol. 2009;16(10):1223–1230.
  • Ream JM, Doshi A, Lala SV, et al. High spatiotemporal resolution dynamic contrast-enhanced MR enterography in Crohn disease terminal ileitis using continuous golden-angle radial sampling, compressed sensing, and parallel imaging. AJR Am J Roentgenol. 2015;204(6):W663–W669.
  • Hectors SJ, Gordic S, Semaan S, et al. Diffusion and perfusion MRI quantification in ileal Crohn’s disease. Eur Radiol. 2019;29(2):993–1002.
  • Brahme F, Lindström C. A comparative radiographic and pathological study of intestinal vaso-architecture in Crohn's disease and in ulcerative colitis. Gut. 1970;11(11):928–940.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.